StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Galmed Pharmaceuticals Trading Down 54.3 %
GLMD opened at $6.90 on Friday. Galmed Pharmaceuticals has a 12 month low of $2.73 and a 12 month high of $23.80. The business’s 50-day moving average price is $3.90 and its 200-day moving average price is $4.14. The company has a market cap of $34.81 million, a P/E ratio of -2.88 and a beta of 0.67.
Galmed Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Galmed Pharmaceuticals
- How Technical Indicators Can Help You Find Oversold Stocks
- How Much Can You Make in Stocks in One Month?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- This Is the Top Large-Cap Stock Insiders Are Buying
- 5 discounted opportunities for dividend growth investors
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Galmed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galmed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.